Compound Management & Integrity Online 2011

Evaluating Compound Management Strategies and Technologies From Around the World

Meet your Speakers

Click on a photo to view their bio
  • Mark Wigglesworth
  • Edgar Specker
  • Maximiliano Zaragoza-Sundqvist
  • David Gray
  • Rose Gonzales
  • Guang Yang
  • Ying Huang
  • Robert Schmitt
  • Johannes Knop
  • Pierre Baillargeon
  • François Le Goff
  • Julien Grimont
  • David Lahr

After 8 successful years of real-world conferences, the annual Compound Management & Integrity series of events is going online! With travel restrictions tighter than ever and a growing interest in compound management (CM) around the world, we’re bringing the experts to you in a series of expert-led interactive webinars beginning October 31, 2011.


Robert Schmitt
Manager, Molecular Services
GPRD Advanced Technology
Abbott Laboratories


Bill Skinner and Toby Winchester
Senior Principal Scientists

Never fear: you don’t need to bid the real-world CM event (and the networking opportunities it provides) farewell. If you have the time, we’d love to see you at our CM events in London, Germany and the US. But if you can’t attend – or need some CM insights between now and next year’s event – join us online this autumn!


True to form, Compound Management & Integrity Online delivers the hard-hitting, technical content you need to consider when managing, optimising and building a successful sample collection for drug discovery research. In these interactive webinars, CM experts will demonstrate how to tackle challenges such as the ongoing trends of downsizing and outsourcing, and will help you identify tools and develop strategies for ensuring the quality of your processes, collaborating with partners (including CROs and academic research organisations) and improving your automation systems for increased efficiency. 

In order to accommodate your schedule, we have spread this event over the course of 5 weeks so that you may attend at your convenience. Presentations will also be available on demand so if you miss a session, you will always have an opportunity to catch up at a time that is convenient!

Be sure to secure your spot on the only online compound management summit.

We look forward to seeing you online!

Kaitlen Jay Exum
Conference Director
Pharma IQ

PS: Don't forget -- even if you miss a live webinar, all sessions will be available on demand at your convenience!
PPS: Learn as a team! Take advantage of our substantial group discounts.

Compound Management & Integrity Online – Industry Report
Right click on the image below and choose Save As

Event Highlights

Hear from compound management experts about:

  • How to develop successful collaborative relationships with external partners, including academic research facilities and CROs 
  • Ensuring quality in both your materials and your processes 
  • Addressing the “why” of compound libraries: how to prioritise what compounds are stored, bearing in mind the realities of storage and management requirements, but keeping your likely future needs in sight as well 
  • Navigating the challenges of collaborating with international partners, including the Asian markets
  • Assessing available automation options and augmenting (and improving) your facility's systems for increased efficiency 


This event is ideal for directors, managers, specialists, scientists and engineers dealing with compound management in the following fields:

•           Compound Management
•           Sample Logistics
•           HTS
•           Automation
•           IT/IS
•           Drug Discovery
•           Chemistry
•           Biology
•           Outsourcing


For the first time ever, this interactive event will bring together internationally recognised compound management experts in a convenient, easily accessible online forum. You will be able to interact with the experts in live chats and access all presentations on demand. Simple!


In the comfort of your home or office! No travel expenses or timing conflicts. You can access this online event anywhere you have a computer and an internet connection, plus all sessions are recorded for on-demand repeat viewing at any time.


Beginning October 31 (spread over five weeks to improve learning and accommodate your schedule; scroll down for the full agenda). All sessions are recorded so if you can't make a particular session, don't worry, you'll have access to all sessions to view at your convenience.


Haven’t been to Pharma IQ’s Compound Management & Integrity conference before? Here’s what others have said about our real world event:

"The best place to be if you take your CM job seriously."  -University of Dundee

"Again and again, the best conference for addressing in-depth CM issues."  -Hoffman La Roche

"Very good group of speakers with diverse specialties. Very valuable!”  -Pfizer


Simply register by entering your details into the box at the bottom of this page.

How it Works

1. This online event showcases LIVE, real-time presentations.
Our entire speaker faculty will be presenting their compound management knowledge and expertise via your computer. From the comfort of your home or office, you can listen and watch the presentations in real-time, and interact with the speaker and other CM professionals that share similar challenges.

And if your schedule isn't flexible to the LIVE presentations, don't worry; you'll get recorded versions of ALL sessions, on-demand so that you can participate at your convenience.

2. Interact with the presenters as well as compound management professionals LIVE!

Unlike pre-recorded webinars, this event gives you the opportunity to interact with the experts in real-time. Presentations and discussions take place the moment you log on, and if you have questions or comments while the event is taking place…just ask and you'll get a response instantly!

The virtual rooms are equipped with many features that give you the ability to participate in surveys and polls, desktop sharing, downloadable content, live chat and live Q&A, amongst many other options.

3. Networking is a key contributor to knowledge sharing...

Often when you go to conferences, you exchange business cards with many CM professionals. Usually the conversation stops once you pack up and head back to work. Not here! This online event not only gives you the chance to meet like-minded professionals that are in the same boat as you, you'll be able to have extensive discussions, live ongoing interactivity and continuous sharing of best practices.

Don't forget to join our LinkedIn Event group where you can network and continue to interact with CM professionals like yourself. (Our LinkedIn Group is invite ONLY to event registrants so that you can continue your experience of the event indefinitely, without being harassed by sales pitches and spam!)

Take full advantage of our event-focused Twitter-based chat stream (the hash tag for this event is #compound) where you can interact live with your peers while the event is taking place.

We understand that you don't have much time in your busy schedule, so we have designed this event to accommodate you as best as we can. We've expanded this online event over the course of 5 weeks, with a handful of sessions a week.

And if you can't make it, you'll have access to anything you missed! The recordings will be available for you to view at any time.


The Changing Face of Sample Management
Mark Wigglesworth
  • Reducing your facility’s footprint for leaner operation
  • Focusing on new areas within compound management 
  • New areas they’re working on that they weren’t covering before 
  • Creating goals for the future and acting upon changes currently in progress (such as enhanced collaboration with third parties)

Mark Wigglesworth, Manager, Sample Management Technologies, GlaxoSmithKline


An Academic Compound Library Stored in an Open Access Screening Platform
Edgar Specker
  • Providing open access to academic researchers to support chemical biology
  • Evaluating compound storage with different vendors' stores and comparing industrial to academic CM
  • Extending traditionally internal resources (i.e. a new website designed for electronic submission of compounds) to external partners 
  • Examples of assay developments in the screening unit

Edgar Specker, Head of Compound Management, Leibniz-Insitut für Molekulare Pharmakologie (FMP)


Case Study: Expanding AstraZeneca Mölndal Compound Management Capacity & Services to Support the New R&D Strategy
Maximiliano Zaragoza-Sundqvist
  • Consolidating more work on the Mölndal site without overworking the Compound Management group
  • Re-deploying automated systems and investing in supplementary tools
  • First integration between an RTS high speed cherry picking and reformatting store and a BioCel

Maximiliano Zaragoza-Sundqvist, Senior Research Scientist, AstraZeneca


Compound Management in an Academic Environment – the Dundee Experience
David Gray
  • Assessing the challenges of compound management in an academic environment
  • Focusing on the challenges and innovation that result from limited budgets for capital equipment and off-the peg software
  • Highlighting the successes, the working practices and remaining areas for development

David Gray, Head of Biology, Division of Biological Chemistry, College of Life Sciences, University of Dundee


Doing More with Less in the Wake of Site Closures
Rose Gonzales
  • Managing the transition – lessons learned
  • Applying the 80/20 rule
  • Innovation in the midst of change

Rose Gonzales, Director, Compound Management & Distribution, Pfizer Worldwide Research & Development


Overcoming Compound Management Challenges Unique to China
Guang Yang
Ying Huang
  • Collecting and storing the active ingredients from traditional Chinese medicine (TCM)
  • Navigating customs regulations for international shipping
  • Setting up local compound collections to facilitate access

Guang Yang, Associate Director New Products Development, GlaxoSmithKline R&D China
Ying Huang, Head of Compound Management, GlaxoSmithKline R&D China


Case Study: Addressing the Logistics of Shipping and Receiving Materials Across International Boundaries
Robert Schmitt
  • Surveying current methods and logistics of international shipping
  • Ensuring regulatory compliance and correct documentation
  • Highlighting specific recurring challenges such as customs control, bureaucracy and high turnover rates
  • Please note: this is a case study of Abbott’s experiences only and is not intended to provide legal counsel of any kind. 

Robert Schmitt, Manager, Molecular Services, GPRD Advanced Technology, Abbott Laboratories


Compound Management at a Small, Satellite HTS Centre
Johannes Knop
  • Balancing local requirements with global strategic alignment and integration
  • Modelling requirements for an automated tube store
  • Overcoming smaller site challenges such as constrained lab space
  • Designing processes tailored towards HTS demand

Johannes Knop, Research Operations Senior Manager, Amgen Germany


Addressing Quality Control Issues in Day-to-Day HTS Compound Management Operations
Pierre Baillargeon
  • Common issues encountered with DMSO-solvated compounds in HTS libraries
  • Current methods for identifying and tracking issues in HTS library compound plates
  • Applications of a novel high resolution and imaging processing instrument (HIAPI) for rapid assessment and quality control of HTS library compound library quality

Pierre Baillargeon, Compound Manager, Scripps Florida


Quality Assessment and Concentration Determination of Actelion’s Compound Solutions by Automated LCMS and Quantitative NMR
François Le Goff
Julien Grimont

This presentation will detail the the Compound Management dissolution process as practiced at Actelion, highlighting:

Application of LCMS:

  • High throughput workflow
  • Automatic gradient selection
  • Identity / purity challenges and determination
  • Follow-up analysis

Quantitative NMR: 

  • Concentration determination using an external standard
  • Reliability of the results
  • High throughput


  • Comparison of the data

François Le Goff, Senior Research Associate, Drug Discovery Chemistry QC Specialist, Actelion Pharmaceuticals Ltd
Julien Grimont, Research Associate Chemistry, Actelion Pharmaceuticals Ltd


Designing and Building a Web Application Customized for Ordering and Tracking of Compounds in the Chemical Biology Platform at the Broad Institute
David Lahr
  • Creating Prometheus - a one-stop web site that allows Broad scientists to order compounds
  • identifying the specific workflows that our scientists use, and then building the system to carry these out
    • Provididing scientists with a lot of options for how their compounds are prepared
  • Ordering and tracking data in a structured online format
  • Allowing integration of ordering system with fulfillment system in future

David Lahr, Application Engineer, Broad Institute



This event would be perfect for my colleagues; can I sign up and share my login with them?The event has been designed to be relevant for a wide audience along the entire spectrum from individual capability development to overall organizational effectiveness, so we encourage you to participate with your team.
However, when you sign up, you are given a unique code, which is also tracked directly to your IP address. You will therefore not be able to share the access to your colleagues. However, we are offering substantial group discounts, so encourage your colleagues to sign up -- the larger the group, the greater the discount!

I can't make some of these sessions. Will I be able to get a copy?
Yes. This event is designed so that if you can't attend some presentations, ALL sessions will be made available on demand so that you can view them at your convenience. Even if you do attend the LIVE sessions, you will get access to all the recordings to re-watch at any time.

When are the sessions being offered?
The session timings are outlined next to the individual sessions above. They are all listed in EST, but remember to convert them to the time zone you are located in. Remember...if you can't make any or all of the sessions because of the time difference, don't worry; you will still get access to the recording so you won't miss a thing!
We know that some of these times might be early or late for you, depending on where you are in the world. Unfortunately, this is the price you have to pay for gaining access to such high quality speakers from around the world. The good news is that you don't have to miss a minute, as all presentations are able to be viewed on demand at a time convenient to you.
Where is the event?
The event is located from the comfort of your home or office. No hassle of travel or accommodation expenses are required.

How long is each session?
Each session is 1 hour in length. There will be a 15 minute break between each session that will give you the chance to network with those in your session and ask the presenter questions.
How do you ask questions during the sessions?
For LIVE sessions, the speakers and attendees are set up with LIVE chat, that way the speaker can directly address any questions you may have pertaining to their presentation. For on-demand sessions, you may visit our interactive LinkedIn Group for this event and catch up on anything you might have missed and ask questions of the speakers and your fellow peers.

Can I just buy certain sessions without purchasing the whole event?
Individual session sales are not available. The all-access pass gives you admittance to all sessions plus all additional bonus materials. Not to mention the incredible networking opportunity that you will be able to continue post event.

What if I have technical questions or any other type of questions, who do I contact?
The online event has been designed to be extremely simple and easy to participate in, wherever you are in the world. In the unlikely event that you have any technical difficulties or any questions about the event, you may send an email to customer support at or call us at +1 877-711-2986 and we will respond immediately to your inquiry.

Register for this Online Event


Earlybird 1
Register before
 29 July
Earlybird 2
Register before
29 September
Standard Rate
after 29 September
1 Person
Groups of 2-4 (per person)
Groups of 5+ (per person)
Groups of 10+ (per person)

Already a member? Sign In
All fields are required.
First Name
Last Name
2nd Address
Job Title

Add Another Delegate

Registration for online events also gives you free membership to the Pharma IQ Community. You need this membership to access the online event and it also provides year round information, ideas and interviews from industry leaders plus online networking opportunities!

Payment Policy: Payment is due in full at the time of registration. Your registration will not be confirmed until payment is received and may be subject to cancellation. Discounts cannot be combined and do not apply to registrations that have already been processed.

For IQPC's Cancellation, Postponement and Substitution Policy, please visit

©2014 IQPC. All Rights Reserved. Use of this site constitutes acceptance of our Privacy Policy. The format, design, content and arrangement of this site constitute a trademark of IQPC. Unauthorized reproduction will be actionable under the Lanham Act and common law principles. By registering for this event you will become a member of Pharma IQ.

Not a member? Sign Up

Reasons for Joining

    Address your challenges through knowledge sharing with peers from our global network of specialists.

    Benchmark your business initiatives with the who's who in the field.

    Hear from industry pioneers how to maximize ROI in today's challenging economy.

    And best of all It's FREE!
Sign in using your existing
Pharma IQ account
Username or Email:

Each license is for a term of six (6) months, beginning on the date on which the online event starts, unless another term is specified in the booking confirmation. Access to the event (i) is restricted by IP address to one user per registration; (ii) is intended only for each registrant's individual use; and (iii) may not be shared with other persons or entities, either internally or externally. Should the client attempt to exceed the scope of the license, the client acknowledges that IQPC reserves the right to any course of action up to and including the invoicing the client for non-authorized access and seeking of damages against the Client.

About The Organizer

Pharma IQ, a division of IQPC, is an international online community focusing on providing pharmaceutical professionals with knowledge, information and articles. We are dedicated to creating a learning environment for sharing ideas, best practices and solutions within the pharmaceutical community

Through Pharma IQ, you will be able to access pharmaceutical information resources such as presentations and podcasts, as well as events such as webinars, seminars and conferences.

By signing up to the Pharma IQ membership, you will gain access to our growing database of multimedia presentations from leading pharma practitioners, weekly newsletters to keep you updated on latest pharmaceutical content and Pharma IQ members-exclusive discounts on pharma events that offer solutions to your everyday business problems.

Pharma IQ and IQPC provide useful training courses, conference and expositions for pharmaceutical executives to network and learn the latest pharma business development and trends occurring in organizations today. Pharma IQ focuses on establishing an interactive experience featuring practical, objective and up-to-date insight from pharma industry leaders.

Maximise Your Involvement: Sponsorship and Exhibition Opportunities

The Compound Management & Integrity Online conference is a world first - the only online event dedicated to assessing compound management technologies and methodologies from around the world.
Focused and high-level, the event is an unparalleled platform to initiate new business relationships, launch a new product or raise your profile amongst new markets.
Exhibiting and sponsorship options are extensive, and packages can be tailor-made to suit your individual company's needs.

Packages can include:

  • Live and on demand webinars
  • A featured presentation on the programme - there are only limited slots available, so contact us now to ensure your company is able to utilise this exclusive thought leadership opportunity!
  • Participation in comprehensive and targeted pre-event marketing campaigns
  • Inclusion in our event focused social media strategy
  • Inclusion on the Pharma IQ portal (+22,000 active members)
  • Tailored marketing strategies to suit your organisation’s size, capabilities and individual requirements

Contact us via phone on 0800 652 2363 or +44 (0) 20 7368 9300 or e-mail for more details about sponsoring or exhibiting.

Presented by:

Share to Facebook Share to Twitter Share to LinkedIn More... Print

Want access to a global audience?
Watch to see why leading companies are using
online events to demonstrate thought leadership
in the eyes of a global prospect base.

For more information call +44 20 7368 9536
or email us:

Mark Wigglesworth


Mark Wigglesworth was awarded his Ph.D in 2001 for work conducted on the forced molecular evolution of G protein-coupled receptors for biotechnological application. This was at the University of Leeds within the laboratory of Professor Findlay. Following this he joined GlaxoSmithKline where he continued working within the field of 7 Transmembrane receptors, concentrating on orphan receptor projects as well as the development and utilization of receptor screening systems. Additionally, remaining within the field of lead optimisation he joined the Sample Management department at the beginning of 2008 to lead a team supporting compound provision to iterative chemistry programmes. In this role has responsibility for solution operations across Europe, has worked to evolve Lead Optimisation processing within GSK and has enjoyed the challenges this has brought.

Speaking on: The Changing Face of Sample Management


Edgar Specker

Leibniz-Insitut für Molekulare Pharmakologie (FMP)

Since 2009, Edgar Specker has been the head of quality and compound management at the Screening Unit of the Leibniz Institute for Molecular Pharmacology (FMP), Berlin. Prior to joining FMP, he was a project leader at Jerini AG (now Shire Pharmaceuticals), Berlin, working in research cooperation with ALCON Research Ltd. for an ophthalmic indication. In 2006-2007, Edgar worked as a medicinal chemist at N-Zyme BioTec GmbH (now Zedira GmbH), Darmstadt, where he worked on a project concerning the synthesis of peptide based substrates and inhibitors for structure based drug design of transglutaminases. Previously, Edgar had been doing postdoctoral work as a research fellow at the school of chemistry at the University of Southampton in England and graduate work at Philipps University of Marburg, Germany.

Speaking on: An Academic Compound Library Stored in an Open Access Screening Platform


Maximiliano Zaragoza-Sundqvist


Max started working in the Compound Management group at AstraZeneca R&D Mölndal in 2000 and has since then been involved in numerous acquisitions and implementations of automated systems. After a two year long excursion into the land of physical quality of compounds he returned to compound management in the summer of 2007. Max currently holds a position as Associate Teamleader which involves responsibility for the compound management process in Mölndal along with its automation.

Speaking on: Case Study: Expanding AstraZeneca Mölndal Compound Management Capacity & Services to Support the New R&D Strategy


David Gray

University of Dundee

David Gray is the Head of Biology at the Dundee University Drug Discovery Unit. David grew up on the west coast of Scotland and started his scientific education by studying for a BSc with honours in Pharmacology from the University of Glasgow. He gained his PhD at University College London working on the molecular pharmacology in vascular tissue of calcitonin gene related peptide with Ian Marshall. The molecular pharmacology theme continued into a post-doc position with Steve Nahorski at the University of Leicester before he joined Wellcome Pharmaceuticals in 1995. He moved through GlaxoWellcome and GlaxoSmithKline occupying increasingly senior positions including being Director, Screening and Compound Profiling at Harlow. Over the course of his time in industry, he has been involved in many drug discovery programs across most target classes and many therapeutic areas. He was heavily involved in taking several molecules into late clinical trails and has seen one drug that he helped to develop, Veramyst, making it all the way to the market.

Speaking on: Compound Management in an Academic Environment – the Dundee Experience


Rose Gonzales

Pfizer Worldwide Research & Development

Rose Gonzales currently heads up Compound Management and Distribution, a Pfizer Research Center of Emphasis located in Groton, CT. Rose is a graduate chemical engineer by training. She started her career in the pharmaceutical industry in the late 90’s as a postdoc in Inflammation Biology at Pharmacia & Upjohn. From there, she went on to do HTS and lab automation at Merck, Parke Davis, and Pfizer. Prior to her current role, Rose led the Analytical Chemistry group in Groton.

Speaking on: Doing More with Less in the Wake of Site Closures


Guang Yang

GlaxoSmithKline R&D China

Dr. Yang has been in the pharmaceutical industry for nearly 15 years. He specializes in small molecule drug target validation and assay technology development. He has successfully led multiple discovery programs from target selection to candidate compound identification and validation for various disease indications (eg. cancer, RA, asthma, metabolic syndrome, anti-infectious, etc.) in several global pharmaceutical companies from 1997 to 2008. Dr. Yang joined GSK R&D China in 2008 to facilitate the establishment of platform technology function in support of GSK’s local drug discovery efforts. He works and lives in Shanghai. Recently he expands his role in GSK R&D China focusing on the development and commercialization of transformative drugs in China and the region. Dr. Yang received his Ph.D. in biochemistry from the University of Maryland; his M.S. in organic chemistry from Bucknell University in Pennsylvania; and his B.S. in polymer chemistry from the University of Science & Technology of China.

Speaking on: Overcoming Compound Management Challenges Unique to China


Ying Huang

GlaxoSmithKline R&D China

Ying Huang heads the Compound Management group, which is responsible for compound deposit, inventory, and distribution. Ying helped establish and maintain compound bank, and supported drug discovery projects in GSK R&D China. With the aid of automated liquid handling workstation and automated tube store, efficient compound request and response system was built to support assay screening. Previously, Ying led the protein science group at the Chinese National Human Genome Center in Shanghai; led the cell biology group at Shanghai South Gene Technology Co., Ltd; and worked on the Biogen Collaborative project at Rensselaer Polytechnic Institute, Chemical and Biological Engineering Department.

Speaking on: Overcoming Compound Management Challenges Unique to China


Robert Schmitt

Abbott Laboratories

Bob has been the manager of the primary research compound repository at Abbott Laboratories in Abbott Park, Illinois, USA, for the past 12 of his 25 years at Abbott. He started his Abbott career as an electrical engineer in the Diagnostics Division, helping to develop the Vision desktop clinical chemistry analyzer. The following decade was spent in cellular diagnostics R&D with a focus on flow cytometry and automated leukocyte identification. He then changed divisions, joining the Automation Engineering group in Pharmaceutical R&D, and shortly thereafter was asked to lead the team in the A-Room, Abbott’s nickname for their research compound repository. In this capacity he has focused on building the capabilities of the group to enable order of magnitude increases in capacity and throughput, as well as developing an international logistics expertise within the team to support a global research environment and outsourcing initiative. He has degrees in Electrical Engineering Technology from Michigan Technological University and in Management from Cardinal Stritch University.

Speaking on: Case Study: Addressing the Logistics of Shipping and Receiving Materials Across International Boundaries


Johannes Knop

Amgen Germany

Dr. Johannes Knop is a Research Operations Sr. Manager at Amgen Research GmbH in Regensburg, Germany. He received his PhD in biochemistry from the University of Hannover, Germany specializing in cytokine receptor signal transduction. In 2000, he joined Tularik GmbH, a newly founded subsidiary of Tularik Inc., San Francisco which was acquired by Amgen in 2004. As a scientist in the High-Throughput Screening (HTS) lab, he initially focused on small molecule lead discovery for GPCRs. Since 2008, Dr. Knop oversees the Research Operations & Services group where he is responsible for Sample Management, Pharmacological Safety Profiling, Data Analysis & Management, and EH&S. In 2009, he supported the centralization of Amgen’s HTS operations by implementing a state-of-the-art sample bank at the Regensburg site.

Speaking on: Compound Management at a Small, Satellite HTS Centre


Pierre Baillargeon

Scripps Florida

Pierre Baillargeon is the Compound Manager at Scripps Florida, located in Jupiter, Florida. Pierre holds a master's degree in Computer Engineering from Florida Atlantic University and established the Compound Management team within the Lead Identification/HTS division at Scripps when the lab was established in 2005. The Compound Management team is responsible for supporting both industrial and academic drug discovery efforts with a proprietary >600,000 sample library and the NIH’s >300,000 sample MLPCN collection. Aside from typical Compound Management duties, Pierre develops, assembles and integrates novel automated hardware and software for the purpose of drug discovery. To find out more information about his research, please visit:

Speaking on: Addressing Quality Control Issues in Day-to-Day HTS Compound Management Operations


François Le Goff

Actelion Pharmaceuticals Ltd

François Le Goff received a master degree in Analytical Chemistry at the University of Orléans in France in 1999. He continued his studies at the University Louis Paster of Strasbourg, where he has been graduated with a Post Graduate Diploma equivalent in Biological and Chemical Analysis. He started to work for one year in a Mass Spectrometry Department of Hoffman-La-Roche Ltd. Thereafter, he joined Novartis Pharma in Basel where he set up a lab of high throughput binding screening by LCMS in the Lead discovery Center. In 2005, he decided to join the Analytical Group of Novartis and was in charge of Hit Validation by HTLC/MS of compounds for the Compound Archive. In 2008, he joined Actelion in Allschwil where he supports Chemistry and Compound Management with Analytics, Quality Assessment and High Resolution MS.

Speaking on: Quality Assessment and Concentration Determination of Actelion’s Compound Solutions by Automated LCMS and Quantitative NMR


Julien Grimont

Actelion Pharmaceuticals Ltd

In 1999, Julien Grimont started his undergraduate studies in mathematics, physics and chemistry to obtain the BSc from the University of Haute-Alsace (France) in 2002. He continued his studies at the ENSCMu, the national graduate chemistry school of Mulhouse (France). In 2005, he completed his Master Degree, specialized in Organic and bioorganic chemistry, with a 6-month internship at Actelion Pharmaceuticals. Thereafter, he was hired as a Research Associate in Medicinal Chemistry at Actelion. His main focus is the synthesis of potent GPCR agonists. In addition to performing synthetic organic chemistry, Julien Grimont joined the Actelion NMR-Team in 2007. He attended courses in Karlsruhe (Bruker’s headquarters) to enrich his knowledge regarding NMR techniques. Since 2009, Julien is leading the NMR-Team at Actelion. He has reinforced the collaboration between Actelion and Bruker, and together with his group, has developed new NMR applications dedicated to drug discovery.

Speaking on: Quality Assessment and Concentration Determination of Actelion’s Compound Solutions by Automated LCMS and Quantitative NMR


David Lahr

Broad Institute

Ph.D. Chemistry, MIT National Research Council postdoctoral fellow, National Institute of Standards and Technology Consultant, Tessella, Inc Project Manager / Application Engineer, Broad Institute

Speaking on: Designing and Building a Web Application Customized for Ordering and Tracking of Compounds in the Chemical Biology Platform at the Broad Institute